Enveric Biosciences, Inc.
ENVB· Nasdaq
ENVBEnveric Biosciences, Inc.
Filed May 15, 2026 · 10-Q · 45 days after period end · 0001493152-26-023353
| Metric | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 |
|---|---|---|---|---|
| Net Income | -$1.63M | -$2.18M | -$2.46M | -$4.68M |
| EPS Diluted | -$1.08 | -$14.58 | -$9.21 | -$2.31 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Enveric Biosciences, Inc. · CIK 890821 · Engraved from SEC EDGAR
ended Mar 31, 2026 · filed May 15, 2026 · 45 d after period end
